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ABSTRACT Pyrethroid resistance in malaria vector, An. funestus is increasingly reported across Africa, threatening
the sustainability of pyrethroid-based control interventions, including long lasting insecticidal nets (LLINs). Managing
this problem requires understanding of the molecular basis of the resistance from different regions of the continent,
to establish whether it is being driven by a single or independent selective events. Here, using a genome-wide
transcription proﬁling of pyrethroid resistant populations from southern (Malawi), East (Uganda), and West Africa
(Benin), we investigated the molecular basis of resistance, revealing strong differences between the different African
regions. The duplicated cytochrome P450 genes (CYP6P9a and CYP6P9b) which were highly overexpressed in
southern Africa are not themost upregulated in other regions, where other genes aremore overexpressed, including
GSTe2 in West (Benin) and CYP9K1 in East (Uganda). The lack of directional selection on both CYP6P9a and
CYP6P9b in Uganda in contrast to southern Africa further supports the limited role of these genes outside southern
Africa. However, other genes such as the P450 CYP9J11 are commonly overexpressed in all countries across Africa.
Here, CYP9J11 is functionally characterized and shown to confer resistance to pyrethroids and moderate cross-
resistance to carbamates (bendiocarb). The consistent overexpression of GSTe2 in Benin is coupled with a role of
allelic variation at this gene as GAL4-UAS transgenic expression in Drosophila ﬂies showed that the resistant 119F
allele is highly efﬁcient in conferring both DDT and permethrin resistance than the L119. The heterogeneity in the
molecular basis of resistance and cross-resistance to insecticides in An. funestus populations throughout sub-Saharan
African should be taken into account in designing resistance management strategies.
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Malaria remains one of the main causes of morbidity and mortality in
Sub-Saharan Africa, predominantly in children under 5 yr and preg-
nant mothers (WHO 2015). Anopheles funestus s.s. is one of the major
malaria vectors in Sub-Saharan Africa and is widely distributed across
the continent (Gillies and De Meillon 1968). The important role of
An. funestus in malaria transmission is supported by recent reports
indicating high Plasmodium falciparum parasite infection rates in this
vector in many Sub-Saharan countries (Coetzee and Koekemoer 2013;
Dia et al. 2013). Malaria vector control relies heavily on the use of a
single insecticide class—the pyrethroids. Pyrethroids are safe and fast
acting (Zaim et al. 2000), and are the only class of insecticides approved
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for use on insecticide treated materials such as Long Lasting Insecticide
Nets (LLINs) (http://www.who.int/whopes/en/). As in other malaria
vectors, pyrethroid resistance in An. funestus has increasingly been
reported in Sub-SaharanAfrica from different regions, including south-
ern [South Africa (Hargreaves et al. 2000; Brooke et al. 2001), Mozam-
bique (Casimiro et al. 2006; Cuamba et al. 2010), Malawi (Hunt et al.
2010; Wondji et al. 2012)], East [Uganda and Kenya (Morgan et al. 2010;
Mulamba et al. 2014) and Tanzania (Lwetoijera et al. 2014)], Central
[Cameroon (Wondji et al. 2011; Menze et al. 2016)], or West Africa
[Benin (Djouaka et al. 2011, R. Djouaka et al. 2016), Ghana (Okoye
et al. 2008; Riveron et al. 2016), Senegal (Samb et al. 2016) and Nigeria
(Ibrahim et al. 2014; R. J. Djouaka et al. 2016)]. These increasing reports of
pyrethroid resistance in malaria vectors such as An. funestus is of great
concern as it poses serious threats to the effectiveness of themalaria vector
control tools across the continent (WHO 2012). Thus, the urgent calls to
develop and implement suitable resistance management strategies against
malaria vectors, to ensure sustainable effectiveness of malaria vector con-
trol interventions. Understanding the molecular basis of insecticide re-
sistance inmalaria vectors is critical for designing and implementing these
resistance management strategies.
Cases of pyrethroids resistance reported so far in An. funestus pop-
ulations are mainly caused by metabolic resistance mechanisms, with no
evidence of target-site resistance through knockdown resistance (kdr)
(Amenya et al. 2008; Okoye et al. 2008; Wondji et al. 2012; Riveron
et al. 2013). Cytochrome P450s are known to be the primary enzyme
family conferring resistance to pyrethroids. Molecular studies conducted
in southern Africa, notably in Malawi and Mozambique, have revealed
that the duplicated P450 genes, CYP6P9a, and CYP6P9b are the main
genes driving pyrethroid resistance in this species in this region (Amenya
et al. 2008; Wondji et al. 2009; Riveron et al. 2013). However, studies
performed in Zambia suggested a diminishing role of these two dupli-
cated P450s northward (Riveron et al. 2014a; Thomsen et al. 2014).
Furthermore, a recent study has revealed a similarminor role ofCYP6P9a
and CYP6P9b across a south-north transect in Malawi, with low expres-
sion of these two genes in the north in contrast to high levels in the south,
coupled with a nearly ﬁxed resistant haplotype (Barnes et al. 2016). This
variation of expression proﬁles in southern Africa suggests that there
could also be signiﬁcant differences in the underlying genetic drivers of
pyrethroid resistance across African populations of An. funestus. How-
ever, the molecular basis of pyrethroid resistance in An. funestus in other
African regions, such as in East or West Africa, remains poorly charac-
terized despite the high level of pyrethroid resistance also reported in
these regions (Okoye et al. 2008; Morgan et al. 2010; Djouaka et al.
2011; Mulamba et al. 2014).
Here, using a microarray genome-wide transcription analysis, we
characterized the molecular basis of pyrethroid resistance in this major
vector inWest and East Africa and through a comparative analysis with
southern African populations, we revealed sharp difference in the key
genes driving resistance in each region. The P450 CYP9J11 commonly
overexpressed in all countries was functionally characterized, and
shown to confer resistance to pyrethroids and moderate cross-
resistance to carbamates. In addition, allelic variation in the glutathione
S-transferase gene, GSTe2, through the L119F mutation (Riveron et al.
2014b) was established to be playing a major role in both DDT and
pyrethroid resistance in Benin.
MATERIALS AND METHODS
Study sites and samples
Blood-fed (F0) females resting indoors were collected between 06.00 AM
and 12.00 PM in Tororo, Eastern Uganda (0.69 N, 34.18 E), in July
2012. Benin samples were collected in Pahou (6 239 N, 2 139 E) in
southern Benin, West Africa in April 2011. The Malawian samples were
collected in the Chikwawa District (0 459 N, 34 59E) in southern
Malawi between July 2009 and April 2010. The F0 collection method
and F1 rearing were conducted as described previously (Djouaka et al.
2011; Riveron et al. 2013; Mulamba et al. 2014). All F0 adults used for
individual oviposition of the above F1 eggs were morphologically identi-
ﬁed as belonging to theAn. funestus group according to the key of Gillies
and Coetzee (1987). A PCR assay was performed using the protocol of
(Koekemoer et al. 2002) to conﬁrm that collected F0 adults were An.
funestus s.s. The study samples were 2- to 5-d-old F1 adult permethrin-
resistant An. funestus s.s. mosquitoes.
Resistance proﬁle of different populations
The resistance patterns of the three populations to various insecticides
was determined as described previously (Djouaka et al. 2011; Riveron
et al. 2013; Mulamba et al. 2014) following the World Health Organi-
zation (WHO) protocol (WHO 1998). The Pahou populations of An.
funestus from Benin is highly resistant toDDT (0%mortality after 1 hr
exposure), resistant to both Type I (permethrin; 66%mortality) and II
(deltamethrin; 88% mortality) pyrethroid, resistant to carbamates
(bendiocarb; 64% mortality), but fully susceptible to malathion
(Djouaka et al. 2011). The Uganda population from Tororo is re-
sistant to pyrethroids [permethrin (33% mortality), deltamethrin
(20% mortality)] and DDT (61% mortality), but susceptible to other
insecticide classes (Mulamba et al. 2014). The Malawi population
from Chikwawa in 2010 was resistant to pyrethroid [permethrin
(47.2% mortality), deltamethrin (42.3% mortality)] and carbamates
(bendiocarb; 60% mortality), moderately resistant to DDT (87.8%
mortality), and fully susceptible to organophosphates (Wondji et al.
2012; Riveron et al. 2013).
Detection of pyrethroid resistance genes
using microarrays
The 8 · 60kAgilentmicroarray chip customdesigned forAn. funestus
used for this study was previously described (Riveron et al. 2014a).
Brieﬂy, each chip contains 60mer probes designed from An. funestus
published ESTs from transcriptome sequencing by 454 (8540) (Gregory
et al. 2011), Illumina (15,527) (Crawford et al. 2010), or An. funestus
cDNAs from GenBank (2850) (two probes for each EST). It also in-
cludes a set of P450 genes from the rp1 and rp2 QTL genomic regions
(Wondji et al. 2009; Irving et al. 2012) (three probes for each gene), the
complete set of Anopheles gambiae transcripts (13,000) (one probe
each), and all of the An. gambiae detoxiﬁcation genes (David et al.
2005) (three probes for each gene). In Benin, we also used the other
4 · 44k An. funestus chip (A-MEXP-2245), previously described
(Riveron et al. 2013) in a triangular experimental design comparing
resistant (R), control (C), and susceptible (S) samples.
The Picopure RNA IsolationKit (Arcturus) was used to extract total
RNA from three biological replicates, each made of batches of 10 2- to
5-d-old F1 An. funestus from each ﬁeld sample that had survived ex-
posure to 0.75% permethrin for 1 hr (R). The same was done also for
the fully susceptible laboratory strain FANG (S). Mosquitoes from
Benin not exposed to insecticide (C) were also extracted. The RNA
extraction was performed as previously described (Riveron et al.
2014a). Complementary RNA (cRNA)was ampliﬁed from each sample
using the Agilent Quick Amp Labeling Kit (two-color) following the
manufacturer’s protocol. The cRNA samples from the susceptible
strain FANG (S) were labeled with the cy3 dye, and cRNAs from the
resistant samples (R) were labeled with cy5 dye. The cRNA quantity
1820 | J. M. Riveron et al.
and quality were assessed before labeling using the NanoDrop and
Bioanalyzer. Labeled cRNAs were hybridized to the arrays for 17 hr
at 65 according to the manufacturer’s protocol. Five hybridizations
were performed for each sample by swapping the biological replicates.
Agilent GeneSpring GX 13.0 software was used to analyze the
microarray data. The differentially expressed genes were identiﬁed
using a threshold of twofold-change (FC) and a statistical signiﬁ-
cance of P , 0.01 with Benjamini-Hochberg correction for multi-
ple testing. The BLAST2GO program was used to predict the
functions of all the transcripts used to design the microarray chip
(Conesa et al. 2005; Gotz et al. 2008). Gene Ontology (GO) enrichment
analyses were preformed using BLAST2GO to detect the major GO
terms over-represented among the sets of probes upregulated in vari-
ous hybridizations and countries in comparison to the reference set
made of the entire transcript set on the microarray chip. The Fisher’s
test was used to assess the statistical signiﬁcance of these tests.
Quantitative RT-PCR validation of the candidate
resistance genes
Quantitative reverse transcription PCR (qRT-PCR) assays were per-
formed to validate microarray results for the key candidate genes; 1 mg
of RNA from each of the three biological replicates—the Resistant (R),
Control (C), and FANG (S)—was used as a template for complemen-
tary (cDNA) synthesis using the superscript III (Invitrogen) following
the manufacturer’s guide. The qRT-PCR was carried out as previously
described (Kwiatkowska et al. 2013; Riveron et al. 2013) with the rel-
ative expression level and FC of each target gene in R and C relative to
S calculated according to the 22DDCT method (Schmittgen and Livak
2008) after normalization with the housekeeping genes ribosomal
protein S7 (RSP7; AFUN007153) and actin5C (AFUN006819). The
primers are listed in Supplemental Material, Table S1 in File S1.
Heterologous expression of candidate genes in
Escherichia coli
Cloning of CYP9J1 for expression in E. coli: The full-lengthCYP9J11
was ampliﬁed from cDNAs (used for qRT-PCR) and cloned into the
pJET1.2/blunt cloning vector (Thermo Scientiﬁc). The primers used are
listed in Table S1 in File S1 as CYP9J11Full F and R. After sequence
analysis, one clone predominant in the three countries was selected for
functional characterization. ThisCYP9J11 allele was fused to a bacterial
ompA+2 leader sequence, and expressed in E. coli JM109 cells using
the pCW-ori+ vector as previously described (Pritchard et al. 1998;
McLaughlin et al. 2008; Stevenson et al. 2011). Brieﬂy, a DNA fragment
containing the coding sequence for the ompA+2 signal peptide
with a downstream alanine-proline linker, and the ﬁrst 20 nt
of CYP9J11 was ﬁrst ampliﬁed using 50 ng of E. coli JM109 DNA as
the template (Primer sets in Table S1 in File S1). Next, this CYP9J11
clone and the ompA+2 PCR fragment were used as templates in a fusion
PCR under the same conditions described previously (Riveron et al.
2014a). The full-length sequence of CYP9J11 incorporating the
ompA+2 leader was ligated into a modiﬁed pCW-ori+ vector plasmid,
pB13 (Pritchard et al. 1998), via EcoRI and XBaI sites to produce
pB13::ompA+2-CYP9J11. This construct was also sequenced to
conﬁrm the absence of PCR errors.
Membrane preparation: Membranes containing CYP9J11 were
obtained by cotransforming the E. coli cells JM109 with pB13::ompA
+2-CYP9J11 with a plasmid containing the An. gambiae cytochrome
P450 reductase, pACYC-AgCPR (McLaughlin et al. 2008). The expres-
sion of CYP9J11, membrane isolation, and determination of P450
content were carried out as previously described (McLaughlin et al. 2008;
Stevenson et al. 2011). Themembraneswere stored in aliquots at280, and
assayed for total protein concentrationusingNanoDrop spectrophotometer,
P450 concentration (Omura and Sato 1964) and CPR activity by monitor-
ing cytochrome c reduction (Strobel and Dignam 1978). The histidine-
tagged An. gambiae cytochrome b5 was generated as previously described
by Stevenson et al. (2011) and used for the metabolism assays.
Metabolism assays: In vitrometabolism reactions between pyrethroids
(deltamethrin and permethrin) and carbamates (bendiorcab and
propuxur) and membranes expressing CYP9J11 were performed
as previously described (Stevenson et al. 2011; Ibrahim et al. 2016a) in
the presence of CPR with cytochrome b5. The reactions consisted of the
following: 45 pmol of P450, 0.2 M Tris HCl pH 7.4, 0.25 mMMgCl2,
1 mM glucose-6-phosphate, 0.1 mM NADP+ (Melford), 1 unit/ml
glucose-6-phosphate dehydrogenase (G6PDH), 0.8 mM cytochrome b5,
and 0.2 mM of test insecticide in a ﬁnal volume of 200 ml.
HPLC analysis: Detection of the reaction outcome followed standard
protocol (Stevenson et al. 2012), with the reactions stopped by addition
of 0.1 ml ice-cold methanol and incubation for 5 min with shaking to
dissolve all available pyrethroids. After a centrifugation of the samples,
150 ml of the supernatant was transferred into HPLC vials; 100 ml
sample was loaded into an isocratic mobile phase of 90% methanol
and 10% water with a ﬂow-rate of 1 ml/min, and substrate peaks were
separated on a 250 mmC18 column (Acclaim 120, Dionex) at 23. The
quantity of pyrethroid remaining in the samples was determined by
reverse-phase HPLC with a monitoring absorbance wavelength of
226 nm (Agilent 1260 Inﬁnity). Percentage depletion was calculated
by comparing the area of the chromatogram from incubation with
NADPH regeneration system to the tubes in which NADP+ was not
added (NADP2). HPLC conditions for analysis of the nonpyrethroid
insecticides was as described in a previous study (Ibrahim et al. 2016b).
Turnover and kinetic assays: TodeterminetheturnoverofCYP9J11with
pyrethroids and bendiocarb, experiments with deltamethrin, permethrin,
and bendiocarb were performed in with incubation time varied from 0 to
30 min. For kinetic constants, incubationwas carried outwith 20 mMeach
of deltamethrin, permethrin, and bendiocarb for 30 min. The turnover and
steady-state kinetic parameters (Km andVmax) were calculated as previously
described (Ibrahim et al. 2015) using the enzyme kinetic module of Graph-
Pad Prism 6.03 (GraphPad Software Inc., La Jolla, CA). Catalytic constants
and efﬁciencies were determined from the steady-state parameters.
Transgenic expression of candidate genes in Drosophila
strains and tests with insecticides
To functionally validate the role of An. funestus CYP9J11 (an ortholog of
CYP9J5 in An. gambiae) in conferring pyrethroid resistance (CYP9J11 is
consistently overexpressed in all three countries), transgenic Drosophila
melanogaster ﬂies expressing this gene were generated using the GAL4/
UAS system. This is to establish whether CYP9J11 overexpression alone
could confer resistance to pyrethroids. The construction of the transgenic
strain followed the protocol we used successfully for the P450s CYP6P9a
and CYP6P9b (Riveron et al. 2013), and CYP6M7 (Riveron et al. 2014a).
Brieﬂy, the same predominant clone used for transgenic expression
was selected to construct transgenic ﬂies, and cloned into the pUASattB
vector using primers containing restriction sites for bglII and XbaI (see
Table S1 in File S1). The PhiC31 system was used to generate the trans-
genic line UAS-CYP9J11 by Genetic Services (Cambridge, MA). Ubiq-
uitous expression of the transgene CYP9J11 in adult F1 progeny
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(experimental group) was obtained after crossing virgin females from
the driver strain Act5C-GAL4 [“y[1] w[]; P(Act5C-GAL4-w)E1/
CyO,”“1;2”] (Bloomington Stock Center, Bloomington, IN) with homo-
zygote UAS-CYP9J11males. Similarly, adult F1 control progeny (control
group) with the same genetic background as the experimental group but
without expression of CYP9J11 were obtained by crossing virgin females
from the driver strain Act5C-GAL4 andUAS recipient linemales (which
do not carry the pUASattb-CYP9J11 insertion).
Insecticide contact bioassays for both experimental and control F1
Drosophila melanogaster females were performed as previously described
(Riveron et al. 2014a) using posteclosion females that were 2–5 d old for
contact assay with the pyrethroids deltamethrin (0.15%) and permethrin
(2%)-impregnated ﬁlter papers prepared in acetone and Dow Corning
556 Silicone Fluid (BHD/Merck, Germany). A total of 20–25 ﬂies was
placed in individual vial containing respective insecticide papers, and the
mortality plus knockdownwas scored after 1, 2, 3, 6, 12 24, 36, and 48 hr
of exposure to the insecticide. For all assays, at least six replicates were
performed. Student’s t-test was used to compare themortality plus knock-
down of the experimental group against the control group.
Investigating the role of allelic variation at GSTe2 in the permethrin
resistance: Due to the overexpression of GSTe2 in mosquitoes resistant
to permethrin in Benin, we used the transgenic expression inDrosophila
to assess whether the allelic variation observed at this gene with the
L119F mutation was playing a role in the observed resistance. A trans-
genic line was generated using the susceptible L119-GSTe2 allele fol-
lowing the same protocol described previously for the resistant allele
119F-GSTe2 as well as for the bioassays with permethrin and delta-
methrin, but also DDT (Riveron et al. 2014b). Student’s t-test was used
to compare the mortality plus knockdown of the L119-GSTe2 group
against the control group and 119F-GSTe2 group.
Genetic diversity of candidate resistance genes
between different An. funestus populations from
different regions of Africa
Genetic variability of CYP9J11: The full-length coding region of
CYP9J11 was ampliﬁed from cDNA of permethrin-resistant samples
from Malawi, Uganda and Zambia to assess the polymorphism of this
gene. The Zambia mosquitoes were collected in Katete district (14 119
099 S, 31 529 099 E) in 2010 as previously described (Riveron et al.
2014a). The ampliﬁcation was performed using the same cDNA syn-
thesized for qRT-PCR with the Phusion polymerase (Thermo Scien-
tiﬁc), which was cloned and sequenced as described above.
Comparative genetic diversity of CYP6P9a and CYP6P9b between
East and southern Africa: To assess whether previously detected
directional selection associated with high overexpression of CYP6P9a
and CYP6P9b genes in southern Africa was also present in East Africa,
mosquitoes from Tororo in Uganda were compared to those from
Chikwawa in Malawi (Riveron et al. 2013). Genomic fragment of both
genes spanning the full-length coding region and a portion of the
59UTR region were ampliﬁed and sequenced directly in 10 susceptible
(dead after 1 hr exposure) from Tororo and 10 resistant mosquitoes
(alive after 1 hr exposure) to 0.75% permethrin. The primers used are
listed in Table S1 in File S1. Polymorphic positions were detected
through manual analysis of sequence traces using BioEdit, and as se-
quence differences in multiple alignments using ClustalW (Thompson
et al. 1994). DnaSP 5.1 (Rozas et al. 2003) was used to deﬁne the haplo-
type phase (through the Phase program), and to assess genetic parameters
of each gene such as nucleotide diversity (p) and haplotype diversity.
A maximum likelihood phylogenetic tree of the haplotypes for each gene
was constructed using MEGA 5.2 (Tamura et al. 2007) to assess the
potential correlation between haplotypes and resistance phenotypes.
Data availability
The microarray data from this study were submitted to Array Express,
accessionnumbersE-MTAB-5375,E-MTAB-5376, andE-MTAB-5424.
The DNA sequences reported in this paper have been deposited in the
GenBank database (accession numbers: KJ150626–KJ150674).
RESULTS
Transcription proﬁling of the pyrethroid resistant
population of Uganda
To detect the set of genes associated with permethrin resistance inUganda,
the 8 · 60k microarray chip was used to compare mosquitoes alive to
permethrin exposure to control (nonexposed) (R-C) and to the fully sus-
ceptible laboratory strain FANG (R-S). The control mosquitoes were also
compared to the susceptible FANG strain (C-S). High numbers of probes
were signiﬁcantly differentially expressed (P , 0.05) for the R-S (7346)
and C-S (7479) comparisons (Figure 1A), most likely due to extensive
genetic differences between the samples. In contrast, for the R-C compar-
ison, a lower number (827) of differentially expressed probes was observed,
as described previously in other similar studies (Riveron et al. 2013) due to
the high level of resistance in the population. Consequently, only 55 probes
were commonly differentially expressed in all three comparisons.
R-S/C-S/R-C: The cytochrome P450 CYP4C27 [Afun012777 using the
ID system set by Crawford et al. (2010)] was the only detoxiﬁcation
gene commonly overexpressed in R-C, R-S and C-S, with highest fold
change in R-S (FC10.3) (Table 1). Other genes had no annotation or no
previous association with insecticide resistance such as an acyl-oxidase
Afun004337 (AGAP011798-RA).
R-S/C-S only:Amongthemostoverexpressedgenescommonlyobservedin
R-S andC-Swereproteases such as a trypsin-relatedprotease (Afun008293),
whichwasthe topupregulatedwithFC187.8 inR-Sand83.07 inC-S.Other
highly overexpressed proteases included chymotrypsin 1 (Afun013921),
with FC64.4 in R-S and 49.5 in C-S. High overexpression of proteases
is commonly reported in resistant mosquitoes either Anopheles
(Kwiatkowska et al. 2013; Riveron et al. 2013), or Aedes albopictus
(Ishak et al. 2016). Several detoxiﬁcation genes were commonly upregu-
lated in both comparisons, with a predominance of cytochrome P450s,
notably CYP6M7 (Afun007663), which was the most overexpressed with
FC70.1 in R-S and 24 in C-S. This P450 has previously been shown to
metabolize pyrethroids (Riveron et al. 2014a). Other highly overexpressed
P450 genes included CYP9K1 (Afun007769) with a higher fold change
(FC21.5) in R-S than previously observed in southern Africa, suggesting a
higher role played by this gene in Uganda. The CYP307A1 (Afun015331)
exhibited a high FC in R-S (FC16.6). Other cytochrome P450s included
CYP6 subfamily genes such as CYP6Z1, CYP6P5, CYP6P4, CYP6Z3,
and, notably, the CYP6M8 (Afun006930), of which the ortholog from
An. gambiae, CYP6M2 is responsible for pyrethroid resistance in this
species (Stevenson et al. 2011; Mitchell et al. 2012) but was not previously
associated with such resistance in An. funestus. A particular transcript
(Afun07369) had a close hit toCYP6P9a, but none of the common probes
for this gene highly overexpressed in southern Africa was observed in
Uganda. CYP4 subfamily genes overexpressed included CYP4H17,
CYP4C36, and CYP4K2, whereas CYP9J11, from the CYP9 subfamily,
was also overexpressed in both comparisons. Glutathione S-transferases
(GSTs) were also signiﬁcantly overexpressed in pyrethroid resistant
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mosquitoes from Uganda compared to the susceptible FANG strain,
notably genes of the epsilon class, includingGSTe1 (Afun013481) (FC6.6
and 5.6, respectively, in R-S and C-S), GSTe5 (Afun009866) and GSTe2
(Afun000045), which, with FC of 2.9 and 2.1, exhibits a lower FC than
the level observed inWest Africa (Riveron et al. 2014b). GST genes from
the Delta class were also overexpressed, including GSTD3 (Afun008354)
(FC6.6 and 5.1) and GSTD1-5 (Afun007499). Other overexpressed de-
toxiﬁcation gene families included sulfotransferases (with Afun013870
having a high FC of 11.9 and 14.8), carboxylesterases, aldehyde oxidases,
ABC transporters, and other genes commonly associated with metabolic
resistance to pyrethroid (Table 1). Cuticular protein genes were also
among the overexpressed genes.
Transcription proﬁling of the pyrethroid resistant
population of Benin
A similar approach was used in Benin using the 4 · 44k chip, as was
carried out before the design of the 8 · 60k. High numbers of probes
were signiﬁcantly differentially expressed for the R-S (5617) and C-S
(7735) comparisons (Figure 1B), most likely due to extensive genetic
differences between the samples. Contrary to Uganda, the R-C com-
parison also showed a high number of probes differentially expressed
(6033), leading to a higher number of probes commonly differentially
expressed in all three comparisons (1890).
R-S/C-S/R-C: The GST GSTe2 (Combined_c920) was the only detox-
iﬁcation gene commonly overexpressed in R-C, R-S, and C-S (Table 2).
Three probes from this gene consistently had a higher overexpression
in the R-S comparison from permethrin surviving mosquitoes vs. sus-
ceptible FANG than in the C-S comparison, supporting its associa-
tion with permethrin resistance, in addition to its role as a main DDT
metabolizer as previously established (Riveron et al. 2014b).
Common probes between two comparisons: Among probes signiﬁ-
cantly overexpressed in at least two comparisons, the cytochrome P450
genes CYP6P9a and CYP6P9b were upregulated in both C-S and R-S,
but with relatively low levels compared to previously reported levels in
southern Africa (,6.4 FC). Two probes of the CYP9J11 were also
upregulated, but between R-C and R-S only (Table 2). Other detoxiﬁ-
cation geneswere upregulated, but only in one comparison. Those found in
R-S included only the cytochrome P450s CYP6Z1 (three probes),CYP6Z3,
CYP6P1, and another probe forCYP6P9a. It also included two ABC trans-
porter genes (probes from An. gambiae transcripts AGAP002182
and AGAP001777, respectively), an aldehyde dehydrogenase, and
cuticular protein genes (Table 2). Genes only present in the C-S com-
parison included an alpha-esterase (COEAE1G; FC5.1) and an UDP
glycosyl transferase. Other detoxiﬁcation genes, including the cyto-
chrome P450s CYP6AA1, CYP6P5, and two GSTs, were upregulated
only in the R-C comparison (Table 2).
GO enrichment analysis
Blast2goenrichmentanalysis forthesetofprobesupregulatedinR-SandC-S
comparisonsdidnotdetectmanyGOtermsrelated todetoxiﬁcationprocess
inmosquitoes. In the case of the C-S comparison in Benin, for example, the
major GO terms over-represented belong mainly to serine-type endopep-
tidase activity, odorant binding activity, protein DNA complex, and others
(Figure S1). Similar results were obtained for other comparisons. The lack
of GO terms associated with detoxiﬁcation is similar to previous studies
with this microarray chip inAn. funestus (Riveron et al. 2013, 2014a). This
is probably caused by the poor annotation of the set of Expressed Sequences
Tags (ESTs) used for the microarray chip, and the composite nature of the
microarray chip made of transcripts from different sources.
Regional comparison of expression proﬁles between
West (Benin), East (Uganda) and southern
(Malawi) Africa
The variation in the underlying resistance mechanisms to pyrethroid
between geographical regions in Africa was analyzed by comparing the
expression proﬁles from Benin and Uganda to that from Malawi in
Figure 1 Transcription proﬁle of pyrethroid resistance
across Benin, Uganda, and Malawi: (A, B) Venn diagram
summarizing the number of probes differentially expressed
in each and between comparisons in (A) Uganda and (B) in
Benin at fold-change (FC).2 and P, 0.05 in R-S, C-S and
R-C comparisons, as well as the commonly expressed
probes. (C) Venn-diagram of the comparison between
Malawi, Uganda, and Benin for the R-S compari-
son only. (D) qRT-PCR expression of key resistance
genes in the three countries when comparing the per-
methrin-resistant mosquitoes to FANG susceptible
(R-S) mosquitoes.
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southern Africa using the 8 · 60k chip. The number of signiﬁcantly
differentially expressed probes is presented in Figure 1C.
Genes common in all regions: Among the genes the most upregulated
in all three regions were a trypsin-related protease gene (Afun008293),
the P450 CYP6M7, the argininosuccinate lyase, and a glycogenin gene.
However, although overexpressed in all regions, the expression levels
vary signiﬁcantly for some genes, such as for CYP6M7, which has a FC
of 131.9 in Benin but only 12.5 in Malawi (Table 3). Among the
detoxiﬁcation genes commonly overexpressed in all three regions,
n Table 1 List of top detoxiﬁcation genes signiﬁcantly overexpressed in pyrethroid resistant An. funestus in Uganda for all comparisons
Probe Transcript An. gambiae ID R-C R-S C-S Description
CUST_12777_PI426302897 Afun012777 CYP4C27 AGAP009246-PA 3.6 10.3 6.8 Cytochrome p450
CUST_8293_PI426302897 Afun008293 AGAP008291-PA 187.8 83.0 Trypsin-related protease
CUST_7663_PI426302897 Afun007663 (CYP6M7) AGAP008213-PA 70.1 24.0 Cytochrome p450
CUST_13921_PI426302897 Afun013921 AGAP006709-PA 64.4 49.5 Chymotrypsin 1
CUST_500_PI426302897 Afun000500 NA 27.1 23.0 Glycogenin
CUST_9227_PI426302897 Afun009227 AGAP008141-PA 22.8 21.2 Argininosuccinate lyase
CUST_7769_PI426302897 Afun007769 (CYP9K1) AGAP000818-PA 21.5 16.1 Cytochrome p450
CUST_15331_PI426302897 Afun015331 (CYP307A1) AGAP001039-PB 16.6 3.9 Cytochrome p450
CUST_11042_PI426302897 Afun011042 AGAP003321-PA 13.3 8.1 Glycine dehydrogenase
CUST_13870_PI426302897 Afun013870 AGAP012697-PA 11.9 14.8 Sulfotransferase
CUST_295_PI406199798 AGAP000177-RA AGAP000177-RA 10.5 8.0 Cuticle protein 7
CUST_4223_PI426302897 Afun004223 (CYP4H17) AGAP008358-PA 10.1 7.5 Cytochrome p450
CUST_15523_PI426302897 Afun015523 AGAP010581-PA 8.1 5.7 abc transporter
CUST_4631_PI406199798 AGAP005698-RA AGAP005698-RA 7.6 3.5 Cuticular protein 4
CUST_1458_PI406199769 combined_c738 6.7 4.9 Short-chain dehydrogenase
CUST_13481_PI426302897 Afun013481 (GSTe1) AGAP009195-PA 6.6 5.6 Glutathione-s-transferase
CUST_3246_PI426302897 Afun003246 AGAP006220-PA 6.5 4.5 Aldehyde oxidase
CUST_8354_PI426302897 Afun008354 (GSTD3) AGAP004382-PA 6.5 5.1 Glutathione transferase
CUST_12343_PI426302897 Afun012343 (CYP4H17) AGAP008358-PA 6.0 4.4 Cytochrome p450 4d1
CUST_11963_PI426302897 Afun011963 AGAP006220-PA 5.7 4.0 Aldehyde oxidase
CUST_11037_PI426302897 Afun011037 AGAP003581-PA 5.7 8.0 Alcohol dehydrogenase
CUST_376_PI406199788 gb-CYP4H25 5.4 5.3 Cytochrome p450
CUST_12197_PI426302897 Afun012197 (CYP304B1) AGAP003066-PA 5.2 3.3 Cytochrome p450
CUST_7127_PI426302897 Afun007127 (CYP4C36) AGAP009241-PA 5.2 2.6 Cytochrome p450
CUST_6930_PI426302897 Afun006930 (CYP6M2) AGAP008212-PA 5.1 5.3 Cytochrome p450
CUST_7861_PI426302897 Afun007861 (CYP6Z1) AGAP008219-PA 4.8 2.5 Cytochrome p450
CUST_10949_PI426302897 Afun010949 AGAP010887-PA 4.6 7.4 Cuticular protein rr-1 family
CUST_7696_PI406199798 AGAP008141-RA AGAP008141-RA 4.6 2.2 Argininosuccinate lyase
CUST_3731_PI406199772 CD577517.1 4.2 4.7 Cuticle protein
CUST_7369_PI426302897 Afun007369 (CYP6P9a) AGAP002865-PA 4.2 3.0 Cytochrome p450
CUST_13871_PI426302897 Afun013871 AGAP012697-PA 4.1 2.3 Sulfotransferase
CUST_13273_PI406199769 combined_c6791 (CYP9J11) AGAP012296-PA 4.1 3.6 Cytochrome p450
CUST_12461_PI426302897 Afun012461 AGAP000288-PA 4.1 6.8 Alcohol dehydrogenase
CUST_7722_PI426302897 Afun007722 AGAP009850-PA 4.0 3.6 Abc transporter
CUST_10360_PI426302897 Afun010360 AGAP006222-PA 4.0 3.2 UDP glucosyl transferases
CUST_9866_PI426302897 Afun009866 (GSTe5) AGAP009192-PA 3.9 2.7 Glutathione-s-transferase
CUST_9492_PI426302897 Afun009492 AGAP001722-PA 3.8 8.8 Carboxylesterase
CUST_7469_PI426302897 Afun007469 (CYP9J11) AGAP012296-PA 3.8 3.0 Cytochrome p450
CUST_15244_PI426302897 Afun015244 AGAP000820-PA 3.7 5.9 Cuticular protein rr-1 family
CUST_10836_PI426302897 Afun010836 AGAP006228-PA 3.4 2.3 Esterase b1
CUST_484_PI406199788 gb-CYP9J3 3.3 2.1 Cytochrome p450
CUST_12666_PI426302897 Afun012666 (CYP315A1) AGAP002429-PA 3.2 3.7 Cytochrome p450
CUST_405_PI406199788 gb-CYP6AD1 3.2 2.0 Cytochrome p450
CUST_9027_PI426302897 Afun009027 AGAP009463-PA 3.1 2.1 Abc transporter
CUST_9335_PI426302897 Afun009335 AGAP003343-PA 3.1 2.8 Cytochrome p450
CUST_720_PI406199788 gb-PX4B 3.1 2.8 Oxidase peroxidase
CUST_10630_PI426302897 Afun010630 (CYP6P5) AGAP002866-PA 3.1 6.3 Cytochrome p450
CUST_45_PI426302897 Afun000045 (GSTe2) AGAP009194-PA 2.9 2.1 Glutathione-s-transferase gst
CUST_10994_PI426302897 Afun010994 (CYP6P4) AGAP002867-PA 2.8 3.2 Cytochrome p450
CUST_30_PI426302915 CYP6Z3 2.8 2.4 Cytochrome p450
CUST_3315_PI406199769 combined_c1675 2.7 2.6 UDP glucosyl transferases
CUST_8909_PI426302897 Afun008909 (CYP4K2) AGAP002416-PA 2.7 3.0 Cytochrome p450
CUST_35_PI406199775 COEAE6O AGAP002863-PA 2.6 3.1 Carboxylesterase
CUST_7499_PI426302897 Afun007499 (GSTD1-5) AGAP004164-PA 2.5 2.1 Glutathione transferase
CUST_9584_PI426302897 Afun009584 (CYP6M4) AGAP008214-PA 2.3 3.2 Cytochrome p450
CUST_3394_PI426302897 Afun003394 (CYP325A1) AGAP000284-PA 2.1 2.1 Cytochrome p450
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cytochrome P450s were again dominant. Most of these P450 genes
showed a similar level of expression in all the three countries, and included
CYP4H17, CYP6Z1, CYP6M4, CYP6M2, CYP9J11, CYP9J13, CYP304B1,
and a gene close to CYP6P9a (Afun007369). Another P450, CYP9K1,
although commonly overexpressed in all three countries, was signiﬁcantly
more highly present in Uganda (FC16.1) than in Malawi (FC2.4) and
Benin (FC6.2), suggesting a bigger role for this gene in Uganda. Other
commonly expressed detoxiﬁcation genes included an aldehyde oxidase
(AGAP006220) and a UDP glucuronosyl transferase (AGAP006222).
Genes common in only two regions: Analysis of the list of genes
commonly overexpressed in only two regions revealed that, for Uganda
and Benin, the GSTs GSTe1 and GSTd3 were common to both coun-
tries, as were the P450s CYP307A, CYP314A1, andCYP315A. For those
overexpressed only in Uganda and Malawi, the P450 CYP4C27 was
detected, although with a higher expression in Uganda (FC10.3) than
in Malawi (FC2.1). The CYP4C36 was also upregulated in both
countries, similar to GSTd1-5. Other genes are also listed in Table
S2 in File S1. The list of genes overexpressed only in Malawi and
Benin is dominated by the CYP6P9a and CYP6P9b with several
probes, but with a far higher overexpression in Malawi for both
genes (e.g., FC39.4 for CYP6P9a in Malawi vs. only FC4.3 in Benin),
suggesting that both genes are mainly driving resistance in southern
Africa.
Some genes common to all countries were detected through
different probes, such as GSTe2, which in Benin and Malawi was
detected by probes against Combined_c920 transcript, whereas in
Uganda and Malawi it was through probes for Afun000045 tran-
script, showing the impact of sequence polymorphism in the
microarray results.
n Table 2 List of top detoxiﬁcation genes signiﬁcantly overexpressed in pyrethroid resistant An. funestus in Benin for all comparisons
Probes Transcript C-S R-C R-S Description
CUST_1822_PI406199769 Combined_c920 11.9 2.6 35.5 Glutathione-s-transferase gst
CUST_1822_PI406199769 Combined_c920 8.8 2.0 25.2 Glutathione-s-transferase gst
CUST_30_PI406199775 Cyp6p9b 3.9 2.9 Cytochrome p450
CUST_25_PI406199775 Cyp6p9a 6.4 2.8 Cytochrome p450
CUST_1616_PI406199772 Ee589516.1 2.3 2.6 D7-related 1 protein
CUST_8241_PI406199769 Combined_c4173 11.6 9.5 Glycoprotein 93
CUST_1964_PI406199772 Cd664227.1 2.4 2.0 Alcohol dehydrogenase
CUST_2550_PI406199769 Combined_c1287 2.4 2.3 Aldehyde dehydrogenase
CUST_3110_PI406199772 Cd577844.1 4.8 4.7 Cuticle protein
CUST_13273_PI406199769 Combined_c6791 (CYP9J11) 2.6 2.5 Cytochrome p450
CUST_13272_PI406199769 Combined_c6791 (CYP9J11) 2.8 2.6 Cytochrome p450
CUST_604_PI406199772 Ee589610.1 3.2 2.8 D7-related 1 protein
CUST_1090_PI406199798 Agap000881-ra 2.1 Aldehyde dehydrogenase
CUST_2068_PI406199798 Agap002182-ra 2.7 ABC transporter
CUST_4410_PI406201128 Agap001777-ra 3.0 ABC transporter
CUST_3109_PI406199772 Cd577844.1 5.0 Cuticle protein
CUST_4919_PI406199772 Bu038983 4.7 Cuticle protein
CUST_3398_PI406199772 Cd577693.1 5.2 Cuticle protein
CUST_48_PI406199775 Cyp6z3 2.5 Cytochrome p450
CUST_10_PI406199775 Cyp6p1 2.1 Cytochrome p450
CUST_43_PI406199775 Cyp6z1 2.4 Cytochrome p450
CUST_45_PI406199775 Cyp6z1 3.3 Cytochrome p450
CUST_27_PI406199775 Cyp6p9a 2.6 Cytochrome p450
CUST_44_PI406199775 Cyp6z1 3.5 Cytochrome p450
CUST_717_PI406199772 Ee589504.1 9.0 D7-related 1 protein
CUST_359_PI406199772 Ee589855.1 9.1 D7-related 1 protein
CUST_1687_PI406199772 Ee589439.1 8.2 D7-related 1 protein
CUST_959_PI406199772 Ee589285.1 3.6 Gsg6 salivary protein
CUST_379_PI406199772 Ee589823.1 2.2 Gsg7 salivary protein
CUST_5934_PI406199769 Combined_c3002 2.4 Superoxide dismutase
CUST_21644_PI406201128 Agap006867-ra 5.2 Adult-speciﬁc cuticular protein acp-20
CUST_120_PI406199788 Gb-COEAE1G 5.1 Alpha-esterase
CUST_21714_PI406201128 Agap010906-ra 3.6 Cuticle protein
CUST_2401_PI406199769 Combined_c1211 2.1 Glucosyl glucuronosyl transferases
CUST_178_PI406199772 Ee590018.1 2.2 Gsg7 salivary protein
CUST_6_PI406199775 Cyp6aa1 2.0 Cytochrome p450
CUST_11_PI406199775 Cyp6p1 2.5 Cytochrome p450
CUST_24_PI406199775 Cyp6p5 2.1 Cytochrome p450
CUST_26_PI406199775 Cyp6p9a 2.2 Cytochrome p450
CUST_1682_PI406199772 Ee589442.1 2.5 D7 protein
CUST_1182_PI406199772 Ee589982.1 2.5 D7-related 1 protein
CUST_892_PI406199772 Ee589340.1 2.8 D7-related 3 protein
CUST_3946_PI406199772 Cd577403.1 3.2 Glutathione s-transferase
CUST_14377_PI406199769 Combined_c7513 2.6 Glutathione transferase
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Quantitative RT-PCR: Key genes exhibiting striking differences
between regions (CYP6P9a, CYP6P9b, and GSTe2) or commonly
overexpressed in all three countries (CYP9J11) were further vali-
dated by qRT-PCR. Analysis of the expression patterns conﬁrmed
the differences observed with microarrays, as both CYP6P9a and
CYP6P9b were highly overexpressed only in Malawi, but just barely
in Uganda and Benin, as seen with microarray (Figure 1D). Simi-
larly, the GSTe2 was highly overexpressed in Benin permethrin re-
sistant individuals (FC 73.1), but only very low-level expression of
this gene was observed in Uganda and Malawi. The common over-
expression of the CYP9J11 was also validated in all three countries,
although at a lower fold-change compared to the other genes.
Functional characterization of key genes commonly
overexpressed in all countries
Several genes (notably P450s) commonly overexpressed in the three
geographical regions are located in the chromosomal regions span-
ning the three QTL (rp1, rp2, and rp3) previously detected for
pyrethroid resistance in An. funestus (Wondji et al. 2009). Although
the key genes driving resistance in rp1 and rp2 have already been
characterized (Irving et al. 2012; Riveron et al. 2013), the genes
driving resistance in rp3 remain uncharacterized. The CYP9J11
overexpressed in all three regions, and located in the 3L chromo-
somal region spanning the rp3 QTL, could be the pyrethroid metab-
olizer gene in this QTL. To validate this hypothesis, we performed a
functional characterization of this gene.
Polymorphism analysis of CYP9J11: Analysis of the genetic variability
of CYP9J11 full-length cDNA (1644 bp) for ﬁve clones each from
Malawi and Zambia, and four from Uganda revealed a high polymor-
phismof this gene, with an average of 93 polymorphic sites observed for
all combined 14 sequences and 17 amino acid changes observed in total
(Table S3 in File S1). No evidence of directional selection was detected
onCYP9J11, as shown by the lack of signiﬁcant TajimaD and Fu and Li
D’ estimates. No speciﬁc clades per the location of origin was ob-
served between haplotypes, although the genetic distance tree revealed
a closer genetic similarity betweenMalawi and Zambia than Uganda, as
expected from geographical distance (Figure 2, A and B).
Functional validation of CYP9J11 using heterologous
expression in E. coli and metabolism assays
Pattern of expression of CYP9J11: On average, CYP9J11 protein
consistently expressed at low concentration (0.13 6 0.007 nmol/mg
protein) compared with previous estimates reported for CYP6M7
(0.15 6 0.0 nmol/mg protein), and for CYP6P9a (0.42–1.0 nmol/mg)
and CYP6P9b (0.35–0.42 nmol/mg), respectively.
Assessment of CYP9J11 pyrethroid activities and cross-resistance
using metabolism assays: Disappearance of 20 mM insecticide sub-
strateswas determined after 90 min of incubationwith the recombinant
CYP9J11 in the presence of cytochrome b5 and NADPH regeneration
system. CYP9J11 metabolized permethrin and deltamethrin with signif-
icant depletions of 88.05% 6 3.23 (P , 0.0001) and 95.05% + 0.74
n Table 3 Detoxiﬁcation genes commonly upregulated in Uganda (UG), Malawi (MAL), and Benin (BN) countries
Probe Name An. funestus ID An. gambiae ID UG MAL BN Description
CUST_8293_PI426302897 Afun008293 AGAP008291-PA 83.0 32.5 74.4 Trypsin-related protease
CUST_7663_PI426302897 Afun007663 (CYP6M7) AGAP008213-PA 24.0 12.5 131.9 Cytochrome p450
CUST_500_PI426302897 Afun000500 23.0 8.8 17.1 Glycogenin
CUST_9227_PI426302897 Afun009227 AGAP008141-PA 21.2 66.3 29.2 Argininosuccinate lyase
CUST_8887_PI426302897 Afun008887 AGAP011997-PA 17.6 8.5 7.3 Nucleotide binding protein 2 (nbp 2)
CUST_7769_PI426302897 Afun007769 (CYP9K1) AGAP000818-PA 16.1 2.4 6.2 Cytochrome p450
CUST_1392_PI426302897 Afun001392 10.7 8.8 6.0 Glycine dehydrogenase
CUST_11042_PI426302897 Afun011042 AGAP003321-PA 8.1 18.5 6.4 Glycine dehydrogenase
CUST_4223_PI426302897 Afun004223 (CYP4H17) AGAP008358-PA 7.5 6.8 9.5 Cytochrome p450
CUST_10949_PI426302897 Afun010949 AGAP010887-PA 7.4 3.0 4.2 Cuticular protein rr-1 family
CUST_1459_PI406199769 combined_c738 7.3 6.4 10.9 Short-chain dehydrogenase
CUST_6930_PI426302897 Afun006930 (CYP6M2) AGAP008212-PA 5.3 4.3 5.0 Cytochrome p450
CUST_3246_PI426302897 Afun003246 AGAP006220-PA 4.5 3.8 4.2 Aldehyde oxidase
CUST_1563_PI406199772 EE589574.1 4.4 2.1 2.8 D7-related 1 protein
CUST_12343_PI426302897 Afun012343 (CYP4H17) AGAP008358-PA 4.4 2.9 4.2 Cytochrome p450 4d1
CUST_8347_PI426302897 Afun008347 AGAP009828-PA 3.9 4.2 5.0 Chymotrypsin 1
CUST_9522_PI426302897 Afun009522 (CYP9J13) AGAP012292-PA 3.5 4.5 2.8 Cytochrome p450
CUST_1710_PI406199772 EE589412.1 3.3 2.2 2.6 D7-related 1 protein
CUST_12197_PI426302897 Afun012197 (CYP304B1) AGAP003066-PA 3.3 2.8 4.1 Cytochrome p450
CUST_10360_PI426302897 Afun010360 AGAP006222-PA 3.2 2.0 4.8 Glucosyl glucuronosyl transferases
CUST_9584_PI426302897 Afun009584 (CYP6M4) AGAP008214-PA 3.2 3.2 3.3 Cytochrome p450
CUST_27_PI426302915 CYP6Z1 3.1 2.5 2.3 Cytochrome p450
CUST_198_PI406199772 EE590001.1 3.0 2.1 3.1 D7-related 1 protein
CUST_7369_PI426302897 Afun007369 (CYP6P9a-like) AGAP002865-PA 3.0 2.5 4.4 Cytochrome p450
CUST_7469_PI426302897 Afun007469 (CYP9J11) AGAP012296-PA 3.0 3.1 2.7 Cytochrome p450
CUST_3109_PI406199772 CD577844.1 2.9 2.5 2.4 Cuticle protein
CUST_9335_PI426302897 Afun009335 AGAP003343-PA 2.8 2.7 2.7 Cytochrome p450
CUST_2473_PI426302897 Afun002473 AGAP000553-PA 2.5 4.5 2.5 ATP-binding-cassette protein
CUST_7861_PI426302897 Afun007861 AGAP008219-PA 2.5 3.1 2.2 Cytochrome p450
CUST_1097_PI406199769 Combined_c557 2.5 6.4 5.1 Trypsin
CUST_10_PI426302915 CYP6M4.seq 2.4 2.6 3.2 Cytochrome p450
CUST_798_PI426302897 Afun000798 (CYP6M2) AGAP008212-PA 2.1 2.5 2.6 Cytochrome p450
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(P , 0.0001), respectively (Figure 3A). These depletions were
higher than obtained with both CYP6P9a and CYP6P9b alleles
(Riveron et al. 2013, 2014a). Carbamates bendiocarb and propoxur,
as well as the organophosphate malathion, were screened to inves-
tigate potential cross resistance by CYP9J11. Low and nonsigniﬁcant
depletion was observed against DDT and malathion (Figure 3A), as
observed previously from CYP6P9a, CYP6P9b, and CYP6M7. This
result is consistent with malathion susceptibility across Africa so
far. CYP9J11 signiﬁcantly depleted bendiocarb; but with a lower de-
pletion of 38.34% 6 7.01 (P , 0.05) than previously reported for
CYP6Z1 (54.72% 6 0.45, P , 0.05) (Ibrahim et al. 2016a). In con-
trast to incubations with CYP6M7, CYP6P9a, and CYP6P9b (,10%
depletions), CYPJ11-mediated metabolism of bendiocarb proceeded
with polar metabolites eluting in the beginning of the HPLC chromato-
gram (Figure 3B). Initial reaction of carbamate metabolism has been
described to produce very polar products that remain at the origin of
the chromatogram (Kuhr 1970) and such highly polar metabolites have
been recently described in metabolisms assay with bendiocarb and
An. funestus CYP6Z1 protein (Ibrahim et al. 2016a).
Kinetics parameters of CYP9J11 metabolism of insecticides: The
CYP9J11-mediated metabolism of permethrin and deltamethrin follows a
Michaelis-Menten pattern (Figure 3, A and B), but a decline in activity was
observed with deltamethrin above 12.5 mM concentration, attributed to
substrate or product inhibition. The turnover (Kcat) and KM obtained with
permethrin was 9.260 min21 6 1.048 and 14.39 mM 6 3.12 leading
to a catalytic efﬁciency of 0.643 min21 mM21 6 0.157. The turn-
over for deltamethrin (4.338 min21 6 1.381) was, on average, half
the value obtained with permethrin, but the afﬁnity of CYP9J11
toward deltamethrin was surprising higher (KM of 7.957 6 1.31).
The catalytic efﬁciency of CYP9J11 for deltamethrin was calculated
as 0.545 min21 mM21 6 0.195, lower than obtained with permeth-
rin. The catalytic efﬁciency of this enzyme toward permethrin is
higher than obtained from An. funestus pyrethroid metabolizers
CYP6P9a and CYP6P9b (Riveron et al. 2014a).
CYP9J11 was also tested with 20 mM bendiocarb and was shown
to behave in allosteric fashion with this carbamate insecticide, with
positive cooperativity (Hill coefﬁcient, h = 2.29 6 0.38) as de-
scribed to be the case of some P450s (Atkins 2004). CYP9J11 por-
trayed sigmoidal curve with relatively low Khalf (lower than KM
obtained with pyrethroids) and low maximal catalytic rate (Figure
3C). The dose-response curve was thus modeled using the GraphPad
prism with relevant module as described (Copeland 2004). The Vmax
and Khalf (KM) for bendiocarb were calculated as 0.04 min21 6 0.005
and 0.75 mM 6 0.2, respectively, leading to a very low catalytic efﬁ-
ciency of 0.053 min21 mM21 6 0.0157, 12 times lower than com-
pared with the values obtained with permethrin.
Transgenic expression of candidate genes in
Drosophila ﬂies
Validation of role of CYP9J11: To conﬁrm that CYP9J11 overtran-
scription alone can confer pyrethroid resistance, transgenic D. mela-
nogaster individuals were generated expressing CYP9J11 (derived from
permethrin resistant ﬁeldmosquitoes fromUganda) under the control of
the ubiquitous Act5C-GAL4 driver. Contact bioassays performed with
2% permethrin (type I pyrethroid) and 0.15% deltamethrin (type
II) revealed that CYP9J11 overtranscription alone is sufﬁcient to
confer resistance to this class of insecticide. For deltamethrin, the
ﬂies overexpressing CYP9J11 were resistant with a signiﬁcantly re-
duced mortality/knockdown rate compared to that observed for control
ﬂies (Figure 4A). Signiﬁcantly reduced mortality/knockdown rates were
recorded at all nine different exposure times for transgenic Act5C-
CYP9J11 individuals when compared with the control group not
expressing CYP9J11. For example, mortality rates were 1.04 6 1% vs.
50.3 6 4.4% (P , 0.001) at 1 hr, 9.5 6 1.7% vs. 74.7 6 6.32%
(P , 0.001) at 2 hr and 56.03 6 4.6% vs. 98.3 6 3.3% (P , 0.001)
at 24 hr (Figure 4A). These results demonstrate that CYP9J11 over-
transcription alone is sufﬁcient to confer resistance to deltamethrin.
For permethrin, signiﬁcantly reduced mortality/knockdown rate
was recorded for transgenic Act5C-CYP9J11 ﬂies when compared
with the control after 1 hr exposure (3.33 6 3.3% vs. 18.36 6 3.8%;
P , 0.05). However, similar mortality rates were recorded for both
experimental and control samples at the rest of the exposure times, with
no signiﬁcant differences observed (Figure 4B).
Conﬁrmation of role of allelic variation of GSTe2 in both DDT and
pyrethroid resistance: Due to the consistent overexpression of GSTe2
in permethrin-resistantmosquitoes in Benin where the L119Fmutation
is ﬁxed, the role of the allelic variation on this gene was investigated
using transgenic expression. Comparative bioassays performed between
a transgenic line expressing the susceptible L119 allele, and another one
expressing the 119F resistant allele, revealed that the 119F mutation
confers a higher resistance against both DDT and permethrin. For
DDT, no mortality is observed in the ﬂies expressing the resistant
119F allele for all the different exposure times, whereas signiﬁcantly
higher mortality rates were observed for the ﬂies expressing the
Figure 2 Genetic diversity pattern of CYP9J11 in East (Uganda; UG)
and southern [Malawi (MAL) and Zambia (ZB)] Africa. (A) Maximum
likelihood tree of CYP9J11 from the cDNA haplotypes of the full-
length 1644 bp sequence. (B) Genetic distances between African
populations (Nst estimates) between the three countries.
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susceptible L119 allele from 24 to 72 hr exposure time (2.2–63%; P,
0.001) (Figure 4C). However, the fact that these mortality rates for
ﬂies expressing the susceptible L119 allele were lower than for ﬂies
not expressing the GSTe2 (2.226 1.4, 18.656 7.1, and 62.696 9.6%
vs. 85.126 8.4, 98.336 1.7 and 100%; P, 0.001; respectively at 24,
48, and 72 hr) suggests that even overexpression of the susceptible
allele provide resistance against DDT in ﬂies, but at a signiﬁcantly
lower level than with the 119F resistance allele. Bioassays with per-
methrin revealed that only ﬂies expressing the resistant 119F allele
had signiﬁcantly lower mortality rate compared to control ﬂies not
expressing GSTe2 (2.78 6 2.7, 10.52 6 2.1, 16.74 6 4.3, and
46.40 6 6.07% vs. 27.98 6 8.3, 55.44 6 10.4, 69.60 6 8.4, and
74.81 6 7.8%; P , 0.01; respectively at 1, 2, 3, and 6 hr exposure
time) (Figure 4D). Flies expressing the susceptible L119 allele showed
the same high mortality rates as the control ﬂies. Each GSTe2 allele was
conﬁrmed to be expressed only in the F1 progeny of the GAL4/UAS
crosses by qRT-PCR (Figure 4E).
CYP6P9a and CYP6P9b polymorphisms in Uganda in
comparison to southern Africa
A comparative analysis of the polymorphism pattern of the duplicated
P450 genes CYP6P9a and CYP6P9b was performed between permeth-
rin-resistant and -susceptible mosquitoes fromUganda and those from
Malawi. The aim was to assess whether the low expression of these
genes in Uganda correlated with a higher genetic diversity of both genes
in contrast to southern African, where a high overexpression was as-
sociated with a directional selection with reduced genetic diversity
(Riveron et al. 2013, 2014a). Overall, both CYP6P9a and CYP6P9b
genes exhibit a higher genetic diversity in Uganda than in Malawi as
shown by the number of substitutions (50 vs. 13 for CYP6P9a; 45 vs. 12
for CYP6P9b), haplotypes (15 vs. 5 for CYP6P9a; 4 vs. 2 for CYP6P9b),
and estimates of genetic diversity or number of nonsynonymous substi-
tutions (Table S3 in File S1). This higher genetic diversity of both genes in
Uganda correlates with their low overexpression and support a lower
role of both genes in Uganda. However, themaximum likelihood trees of
haplotypes of both genes for Uganda and Malawi (Figure 5, A and B)
revealed that for CYP6P9a, four haplotypes from resistant mosquitoes
clustered with haplotypes from Malawi. These Uganda haplotypes also
exhibit the insertion of two AAs [CAAAAAA(AA)] in the promoter
region characteristic of southern African resistant haplotypes (Ibrahim
et al. 2015). For both genes, haplotypes of both countries cluster in
separate clades (Figure 5, A and B).
DISCUSSION
Elucidation of resistancemechanisms to insecticide inmosquito vectors
of tropical diseases such as malaria is a prerequisite for a better man-
agement of the growing problem of resistance to existing insecticide
classes in public health sectors. If progress has beenmade in assessing the
local transcription proﬁles associated with pyrethroid resistance in
malaria vectors in Africa, generating a broader view of the molecular
basis of resistance continent-wide has been limited. The regional
comparison of the transcription proﬁle of pyrethroid resistance in An.
funestus across Africa revealed three main lessons discussed below.
The transcription proﬁle of pyrethroid resistance is not
uniform across the continent
The genome-wide analysis of the transcription proﬁle associated with
pyrethroid resistance highlighted a common trait, i.e., the predominant
role of cytochrome P450 genes in the metabolic resistance observed in
An. funestus population as previously reported in southern Africa
(Riveron et al. 2013, 2014a) and in other mosquito species such as
An. gambiae (Mitchell et al. 2012; Kwiatkowska et al. 2013) or in Aedes
(Strode et al. 2008; Bariami et al. 2012; Saavedra-Rodriguez et al. 2012;
Ishak et al. 2016). However, the drastic difference in the expression
levels of key P450s suggests that the origin of resistance is not the same
across the continent, and that there were independent selection events
of resistance to pyrethroids in various populations. A clear example
is that provided by the expression proﬁle of the duplicated P450s
CYP6P9a andCYP6P9b, the main pyrethroid resistance genes in south-
ern African populations of An. funestus (Amenya et al. 2008; Riveron
et al. 2013, 2014a), but which, from this study, seem to play no or little
role in East Africa, as further supported by their higher genetic diversity
in Uganda than in Malawi but also than in West (Benin and Ghana)
and Central Africa (Cameroon) (Barnes et al. 2017). Such drastic var-
iation is also in line with the gradual reduced expression of CYP6P9a
and CYP6P9b in Zambia compared to Malawi and Mozambique
Figure 3 Functional validation of the role of CYP9J11
P450 gene in carbamate/pyrethroid resistance. (A)
Percentage depletion of 20 mM carbamate and pyre-
throid insecticides with CYP9J11. Results are an aver-
age of three replicates (n = 3) compared with negative
control.  and  Signiﬁcantly different from negative
control (2NADPH) at P , 0.05 and P , 0.01, respec-
tively. (B) Polar metabolites with short retention time
eluted at the beginning of chromatogram of CYP9J11
metabolism of bendiocarb (NADPH+). A third puta-
tive metabolite of bendiocarb metabolism eluted at
18.045 min. (C) Chromatogram of NADPH- incubation
tubes devoid of polar metabolites with short retention
indicating no metabolism of bendiocarb in the absence
of NADPH regeneration agent. (D, E) Michaelis-Menten
plot of CYP9J11 mediated metabolism of permethrin
and deltamethrin, respectively. Results are an average
of three replicates (n = 3) compared with negative con-
trol; (F) Allosteric sigmoidal curve of CYP9J11metabolism of
bendiocarb. Results are average of three replicates (n = 3)
compared with negative control. Khalf = KM; h = 2.29.
1828 | J. M. Riveron et al.
(Riveron et al. 2014a; Thomsen et al. 2014; Barnes et al. 2016), and
suggests barriers to gene ﬂow previously detected between African pop-
ulations of this mosquito species (Michel et al. 2005; Barnes et al. 2017).
Variation in the transcription proﬁles of insecticide resistance genes are
also reported in other mosquito species such asAn. gambiae, where P450
genes such as CYP6P3 and CYP6M2 highly overexpressed in West
(Mitchell et al. 2012; Kwiatkowska et al. 2013) and in Central (Fossog
Tene et al. 2013; Antonio-Nkondjio et al. 2016) Africa are not signiﬁ-
cantly expressed in the southern populations in Zambia (Thomsen et al.
2014). Equally, in contrast, the P450CYP6P4 fromAn. arabiensis has also
been shown to be a major driver of pyrethroid resistance in populations
from Chad (Ibrahim et al. 2016b) and Sudan (Abdalla et al. 2014). It is
therefore important to avoid generalizing the underlying molecular basis
of resistance across countries or the continent, but rather to determine as
much as possible the main resistance genes in the different countries/
regions, efforts that can impact the design of diagnostic tools or resistance
management strategies. For example, the CYP6M2 in An. gambiae (Edi
et al. 2014) and the CYP6Z1 (Ibrahim et al. 2016a) in An. funestus have
been shown to confer cross-resistance between pyrethroids and carba-
mates, so their signiﬁcant overexpression in a population should prevent
using carbamates as alternative to pyrethroids in an IRS campaign.
The cytochrome P450 CYP9J11 is a common African
pyrethroid resistance gene
If signiﬁcant differences are observed between regions, there are also
similarities with common genes observed across the continent such as
the P450CYP9J11whichwas overexpressed in all three regions assessed
here. However, because of its moderate level of expression, CYP9J11
may not be the primary resistance gene. Nevertheless, its signiﬁcant
catalytic efﬁciency in metabolising pyrethroid means it cannot be dis-
regarded.CYP9J11 is the ortholog ofCYP9J5 inAn. gambiae, whichwas
recently shown to alsometabolize pyrethroids and pyriproxyfen, and to
be overexpressed Africa-wide in An. gambiae ﬁeld populations from
West (Toe et al. 2015), Central (Fossog Tene et al. 2013), and East
Africa (Nkya et al. 2014), suggesting that this gene could be important
in providing protection to a wide range of xenobiotics in malaria vec-
tors. CYP9J11 is also located on the 3L chromosome where the rp3
(resistance to pyrethroid 3) QTL had previously been detected,
Figure 4 Functional validation of the role candidate resistance genes using transgenic expression in ﬂies: (A) results of bioassay analysis of
transgenic ﬂies overexpressing CYP9J11 Act5C-CYP9J11 vs. control ﬂies for deltamethrin. (B) The same bioassays with permethrin. (C) Functional
validation of the role of allelic variation at the GSTe2 genes on the resistance phenotype using transgenic expression in ﬂies through a
comparative transgenic analysis of the 119F and L119-GSTe2 alleles using bioassay tests on transgenic Act5C-GSTe2-119F (GSTe2-Benin) and
Act5C-GSTe2-L119 (GSTe2-Malawi) and ﬂies (Exp-GSTe2), control strains [two parental (UAS-GSTe2 and GAL4-Actin) and F1 progeny that do not
express the GSTe2 transgene (Cont-NO)]. (D) The same bioassays with permethrin. (E) Relative expression of the transgene GSTe2 alleles in the
transgenic D. melanogaster strain (Act5C-GSTe2-MAL and Act5C-GSTe2-BN) and the control sample with no GSTe2 expression (Cont Act5c-NO).
Data shown as mean 6 SEM signiﬁcantly different: P , 0.05, P , 0.01, and P , 0.001.
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suggesting that it could be the main gene behind rp3 (Wondji et al.
2005, 2007, 2009). In addition to the ability to metabolize pyrethroids
and confer resistance to An. funestus, CYP9J11 as previously shown for
CYP6Z1 (Ibrahim et al. 2016a) is a cross-resistance gene, able to
metabolize nonpyrethroid insecticides used in public health using
noncanonical Michaelis-Menten kinetic mechanisms. Various P450s
exhibit functional allostery using distributive catalysis to minimize tox-
icological effects of substrates (Atkins et al. 2002), for example, the
promiscuous CYP3A4 (Wang et al. 2000), CYP2C9 (Tracy et al.
2002), and the recently characterized An. funestus CYP6Z1 (Ibrahim
et al. 2016a). At low substrate concentrations, the slower substrate
turnover afforded by cooperative CYPs compared with Michaelis-
Menten enzymes can be a signiﬁcant toxicological advantage, when
toxic thresholds exist (Atkins et al. 2002). Possibly, bendiocarb is too
“toxic” for CYP9J11, even though it can metabolize it, and this is why
P450 employs distributive catalysis to effect its catalysis, as in the case of
An. funestus CYP6Z1 (Ibrahim et al. 2016a).
3-Allelic variation of GST GSTe2 impacts
pyrethroid resistance
The signiﬁcant overexpression of GSTe2 in Benin in pyrethroid re-
sistant mosquitoes (as seen by the FC . 2 in R-C comparing per-
methrin resistant to control, not-exposed, mosquitoes from Pahou)
suggested that this gene could be involved in permethrin resistance.
The signiﬁcant lower mortality observed in transgenic Drosophila
ﬂies expressing the resistant 119F allele compared to those express-
ing the susceptible L119 allele supports the key role that allelic
variation in this gene plays beside its overtranscription. As previ-
ously shown for DDT resistance, it is likely that the 119F also en-
larging the GSTe2 binding cavity to facilitate access of pyrethroid,
and allow either sequestration as suggested for GST action on py-
rethroids (Vontas et al. 2005), or a direct metabolism as established
by Riveron et al. (2014a). The ability of the transgenic expression in
Drosophila ﬂies to establish the phenotypic impact of the allelic
variation of GSTe2 due to a single amino acid change highlights
the robustness of this approach in functionally characterizing the
role of candidate resistance genes in conferring resistance to insec-
ticide. This shows that experimental results from transgenic Dro-
sophila are very relevant to the phenotype obtained in mosquitoes,
while providing the advantage that studies in Drosophila could be
easily scaled up to hundreds of genes, with less work, cost and space
required for storage of transgenic lines. Allelic variation was also
recently shown to play an important role in the pyrethroid resis-
tance conferred by the duplicated P450s CYP6P9a and CYP6P9b in
southern African populations of An. funestus (Ibrahim et al. 2015),
suggesting that, besides overtranscription of detoxiﬁcation genes,
amino acid changes in coding regions could also play a major role.
Such cases will facilitate the design of DNA-based diagnostic tools to
detect metabolic resistance in ﬁeld populations, as done already for
the L119F-GSTe2 mutation (Riveron et al. 2014a).
Conclusion
The comparative transcription analysis performed in this study between
various African regions highlights that, althoughmetabolic resistance is
the commondrivingmechanismofpyrethroid resistance inAn. funestus
populations, there are signiﬁcant special variations on the main genes
associated with it, which could impact patterns of cross-resistance and
resistance management strategies. The impact of many genes confer-
ring resistance and cross-resistance to multiple resistant populations of
An. funestus in sub-Saharan African is a challenge to resistance manage-
ment. This phenomenon makes the resistance highly heterogeneous and
complex, making the design of appropriate diagnostic tools operationally
challenging. There is an overwhelming need for newer classes of insecti-
cides that are safe but potent enough to control mosquito vectors of
malaria and other diseases effectively. But caution must be exercised
because of the presence of a number of detoxiﬁcation enzymes that can
confer cross-resistance, and a new insecticide may already be doomed
before being deployed if resistance genes can already metabolize it.
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